Literature DB >> 18475057

Bone involvement in exogenous hypercortisolism.

L Sinigaglia1, D Mazzocchi, M Varenna.   

Abstract

Corticosteroids remain a key component in the management of many disorders. Bone loss resulting from long-term administration of these drugs is common and osteoporosis induced by corticosteroids is the most frequent cause of secondary osteoporosis in nearly 50% of individuals on chronic corticosteroid therapy suffering from an osteoporotic fracture at some point. This article reviews the epidemiology and pathogenesis of glucocorticoid-induced osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18475057     DOI: 10.1007/BF03346372

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  48 in total

1.  Cortisol regulates the expression of Notch in osteoblasts.

Authors:  Rosa M R Pereira; Anne M Delany; Deena Durant; Ernesto Canalis
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

2.  Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass.

Authors:  T J Hahn; V C Boisseau; L V Avioli
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

3.  Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study.

Authors:  L J Walsh; C A Wong; M Pringle; A E Tattersfield
Journal:  BMJ       Date:  1996-08-10

4.  Influence of glucocorticoids on human osteoclast generation and activity.

Authors:  Sutharshani Sivagurunathan; Meloni M Muir; Tara C Brennan; J Paul Seale; Rebecca S Mason
Journal:  J Bone Miner Res       Date:  2004-12-20       Impact factor: 6.741

5.  Elevated 1,25-dihydroxyvitamin D levels in patients with chronic obstructive pulmonary disease treated with prednisone.

Authors:  D D Bikle; B Halloran; L Fong; L Steinbach; J Shellito
Journal:  J Clin Endocrinol Metab       Date:  1993-02       Impact factor: 5.958

6.  High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton.

Authors:  F Cosman; J Nieves; J Herbert; V Shen; R Lindsay
Journal:  J Bone Miner Res       Date:  1994-07       Impact factor: 6.741

7.  Cortisol downregulates osteoblast alpha 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms.

Authors:  A M Delany; B Y Gabbitas; E Canalis
Journal:  J Cell Biochem       Date:  1995-03       Impact factor: 4.429

8.  Users of low-dose glucocorticoids have increased bone loss rates: a longitudinal study.

Authors:  J K Saito; J W Davis; R D Wasnich; P D Ross
Journal:  Calcif Tissue Int       Date:  1995-08       Impact factor: 4.333

9.  Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess.

Authors:  E Seeman; R Kumar; G G Hunder; M Scott; H Heath; B L Riggs
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

10.  The course of biochemical parameters of bone turnover during treatment with corticosteroids.

Authors:  M F Prummel; W M Wiersinga; P Lips; G T Sanders; H P Sauerwein
Journal:  J Clin Endocrinol Metab       Date:  1991-02       Impact factor: 5.958

View more
  1 in total

1.  An Atraumatic Symphysiolysis with a Unilateral Injured Sacroiliac Joint in a Patient with Cushing's Disease: A Loss of Pelvic Stability Related to Ligamentous Insufficiency?

Authors:  Andreas Höch; Philipp Pieroh; Faramarz Dehghani; Christoph Josten; Jörg Böhme
Journal:  Case Rep Orthop       Date:  2016-01-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.